Table 1 Patient demographics (N=50)
Variables | Results |
|---|---|
Age, years | 67.4±6.1 |
BMI, kg/m2 | 24.1±3.2 |
Prostate volume, mL | 32.6 (18.6) |
Preoperative PSA level, ng/mL | 8.9 (6.3) |
Clinical stage, n (%) | |
T1c | 12 (24.0) |
T2a | 21 (42.0) |
T2b | 7 (14.0) |
T2c | 10 (20.0) |
Biopsy grade group, n (%) | |
Grade group 1 | 19 (38.0) |
Grade group 2 | 16 (32.0) |
Grade group 3 | 11 (22.0) |
Grade group 4 | 4 (8.0) |
NCCN risk group, n (%) | |
Low risk | 14 (28.0) |
Favorable intermediate risk | 13 (26.0) |
Unfavorable intermediate risk | 16 (32.0) |
High risk | 7 (14.0) |
ASA score, n (%) | |
≤2 | 44 (88.0) |
≥3 | 6 (12.0) |
CCI, n (%) | |
0~1 | 47 (94.0) |
≥2 | 3 (6.0) |
Surgical history, n (%) | |
Appendectomy | 2 (4.0) |
Cholecystectomy | 4 (8.0) |
Colectomy | 3 (6.0) |
Gastrectomy | 2 (4.0) |
Hepatectomy | 2 (4.0) |
Ileus | 1 (2.0) |
Inguinal/umbilical hernia repair | 6 (12.0) |
Nephrectomy | 1 (2.0) |
Transurethral resection of the prostate | 1 (2.0) |